Picture [iito] Made Without Love 650x80px
Organisation › Details

MYR GmbH (MYR Pharmaceuticals)

MYR GmbH located in Burgwedel near Hannover was founded in 2010 and holds the world-wide exclusive product rights for Myrcludex. Currently, the company has 2 employees who are focused on the coordination of the network of academic partners and vendors involved in the Myrcludex development. Dr. Alexander Alexandrov, MYR CSO: "We have established a very successful public-private partnership giving birth to a promising and efficient Biotech-company". *


Period Start 2010-12-01 established
  Group Gilead Sciences (Group)
Products Industry virostatic agent
  Industry 2 Hepcludex® (formerly Myrcludex B)
Persons Person Christély, Thomas (MYR GmbH 202008 Managing Director before Atugen AG 200702 CEO)
  Person 2 Vogel, Florian (MYR Pharmaceuticals 202006 CCO)
Region Region Bad Homburg
  Country Germany
  Street 10–12 Thomasstr.
  City 61348 Bad Homburg
  Tel +49-6172-4959811
    Address record changed: 2020-12-02
Basic data Employees A: 1 to 10 (2011-05-12)
    * Document for �About Section�: 
Record changed: 2020-12-13


Picture [iito] Plain Stupid Simple 650x80px

More documents for Gilead Sciences (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top